Style Box ETF report for FDL

3 Unstoppable Dividend Stocks to Buy in September

09:25am, Tuesday, 13'th Sep 2022 The Motley Fool
These stocks offer more than just dividends.
These stocks offer more than just dividends.

AbbVie (ABBV) Gains But Lags Market: What You Should Know

09:45pm, Monday, 12'th Sep 2022 Zacks Investment Research
AbbVie (ABBV) closed the most recent trading day at $142.24, moving +0.58% from the previous trading session.
Mohit Bansal, Wells Fargo, joins 'Closing Bell' to discuss Bristol-Myers shares rising on the FDA approval of its latest drug.
This pair of Midwestern companies have outperformed in recent years, and their futures look brighter than ever.

Should You Invest in the Invesco Dynamic Pharmaceuticals ETF (PJP)?

10:20am, Monday, 12'th Sep 2022 Zacks Investment Research
Sector ETF report for PJP
This pair of Midwestern companies have outperformed in recent years, and their futures look brighter than ever.
"Dividend Aristocrats in the S&P 500 Index have raised their annual payouts every year for at least 25 consecutive years. "--Kiplinger.com/Investing. 65 Aristocrats screened as of September 8, 2022 re
Is now a good time to add these biotech stocks to your watchlist?

Become Financially Independent, Stress-Free In 15 Years

01:00pm, Saturday, 10'th Sep 2022 Seeking Alpha
Being financially independent is a prerequisite for retirees but can be a great stress reducer for younger folks who are several years away from retirement. Read more here.

Bert's August Dividend Income Report | Dividend Investing 2022

08:27am, Saturday, 10'th Sep 2022 Seeking Alpha
Each month, we share our dividend income summaries to highlight our growth and progress. We received $842.78 in August dividend income! This was a 3.54% increase compared to August 2021.

Revance (RVNC) Gets FDA Nod for Anti-Wrinkle Product, Stock Up

06:39pm, Friday, 09'th Sep 2022 Zacks Investment Research
FDA approves Revance Therapeutics' (RVNC) Daxxify as a long-acting neuromodulator with a strong label that includes 36-week efficacy data from the SAKURA clinical program.

Is Most-Watched Stock AbbVie Inc. (ABBV) Worth Betting on Now?

01:00pm, Friday, 09'th Sep 2022 Zacks Investment Research
Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.
Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE